Bruce M Perry

US Patent:

20190008780, Jan 10, 2019

Filed:

Jul 10, 2017

Appl. No.:

15/645954

Inventors:

Bruce Perry - Carefree AZ, US

International Classification:

A61K 9/48
A61K 31/14
A61K 31/7076
A61K 31/56
A61K 31/36
A61K 45/06
A61K 36/28
A61K 36/738
A61K 36/78
A61K 36/744
A61K 36/69
A61K 36/815

Abstract:

The invention comprises a biomedically active/delivery site specific capsule-in-capsule liver supplement and method of use thereof. A first set of constituents, of an outer capsule, of a capsule-in-capsule liver supplement, comprises one or more of choline and phosphatidylcholine; a second set of constituents, of an inner capsule, comprise one or more of methionine, glycyrrhetinic acid, silymarin, and phosphatidylcholine; and either capsule optionally contains one or more liver aiding/regulating natural products, where the outer capsule dissolves in the stomach and the inner capsule dissolves in the small intestine. Thus, the dual dissolution process in controlled environments results in complementary and synergistic delivery of liver regulating molecules in a bioavailable form ready for transport through the wall of the small intestine. Further, constituents of the capsule-in-capsule liver supplement include multiple inputs into the methionine cycle, which facilitates/synergistically aids the body's use of the methionine cycle, such as in liver regulation.